IBDEI0LP ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21884,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,21885,0)
 ;;=E20.0^^89^1038^34
 ;;^UTILITY(U,$J,358.3,21885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21885,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,21885,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,21885,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,21886,0)
 ;;=E20.9^^89^1038^30
 ;;^UTILITY(U,$J,358.3,21886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21886,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,21886,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,21886,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,21887,0)
 ;;=E23.0^^89^1038^31
 ;;^UTILITY(U,$J,358.3,21887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21887,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,21887,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,21887,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,21888,0)
 ;;=E27.1^^89^1038^51
 ;;^UTILITY(U,$J,358.3,21888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21888,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,21888,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,21888,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,21889,0)
 ;;=E27.2^^89^1038^1
 ;;^UTILITY(U,$J,358.3,21889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21889,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,21889,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,21889,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,21890,0)
 ;;=E27.3^^89^1038^23
 ;;^UTILITY(U,$J,358.3,21890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21890,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,21890,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,21890,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,21891,0)
 ;;=E29.1^^89^1038^52
 ;;^UTILITY(U,$J,358.3,21891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21891,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,21891,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,21891,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,21892,0)
 ;;=E55.9^^89^1038^59
 ;;^UTILITY(U,$J,358.3,21892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21892,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,21892,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,21892,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,21893,0)
 ;;=E66.01^^89^1038^38
 ;;^UTILITY(U,$J,358.3,21893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21893,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,21893,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,21893,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,21894,0)
 ;;=E66.8^^89^1038^42
 ;;^UTILITY(U,$J,358.3,21894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21894,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,21894,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,21894,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,21895,0)
 ;;=E66.9^^89^1038^43
 ;;^UTILITY(U,$J,358.3,21895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21895,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,21895,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,21895,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,21896,0)
 ;;=E74.39^^89^1038^35
 ;;^UTILITY(U,$J,358.3,21896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21896,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,21896,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,21896,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,21897,0)
 ;;=E83.30^^89^1038^46
 ;;^UTILITY(U,$J,358.3,21897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21897,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,21897,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,21897,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,21898,0)
 ;;=E83.51^^89^1038^28
 ;;^UTILITY(U,$J,358.3,21898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21898,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,21898,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,21898,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,21899,0)
 ;;=E83.52^^89^1038^26
 ;;^UTILITY(U,$J,358.3,21899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21899,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,21899,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,21899,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,21900,0)
 ;;=E87.5^^89^1038^27
 ;;^UTILITY(U,$J,358.3,21900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21900,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,21900,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,21900,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,21901,0)
 ;;=E89.2^^89^1038^48
 ;;^UTILITY(U,$J,358.3,21901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21901,1,3,0)
 ;;=3^PostProcedural Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,21901,1,4,0)
 ;;=4^E89.2
 ;;^UTILITY(U,$J,358.3,21901,2)
 ;;=^5003037
 ;;^UTILITY(U,$J,358.3,21902,0)
 ;;=E89.6^^89^1038^47
 ;;^UTILITY(U,$J,358.3,21902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21902,1,3,0)
 ;;=3^PostProcedural Adrenocortical Hypofunction
 ;;^UTILITY(U,$J,358.3,21902,1,4,0)
 ;;=4^E89.6
 ;;^UTILITY(U,$J,358.3,21902,2)
 ;;=^5003042
 ;;^UTILITY(U,$J,358.3,21903,0)
 ;;=L68.0^^89^1038^25
 ;;^UTILITY(U,$J,358.3,21903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21903,1,3,0)
 ;;=3^Hirsutism
 ;;^UTILITY(U,$J,358.3,21903,1,4,0)
 ;;=4^L68.0
 ;;^UTILITY(U,$J,358.3,21903,2)
 ;;=^5009262
 ;;^UTILITY(U,$J,358.3,21904,0)
 ;;=M80.00XA^^89^1038^2
 ;;^UTILITY(U,$J,358.3,21904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21904,1,3,0)
 ;;=3^Age-Related Osteoporosis w/ Fx,Unspec Site,Init Encntr
 ;;^UTILITY(U,$J,358.3,21904,1,4,0)
 ;;=4^M80.00XA
 ;;^UTILITY(U,$J,358.3,21904,2)
 ;;=^5013363
 ;;^UTILITY(U,$J,358.3,21905,0)
 ;;=M81.0^^89^1038^3
 ;;^UTILITY(U,$J,358.3,21905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21905,1,3,0)
 ;;=3^Age-Related Osteoporosis w/o Fx
 ;;^UTILITY(U,$J,358.3,21905,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,21905,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,21906,0)
 ;;=M85.80^^89^1038^44
 ;;^UTILITY(U,$J,358.3,21906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21906,1,3,0)
 ;;=3^Osteopenia,Unspec Site
 ;;^UTILITY(U,$J,358.3,21906,1,4,0)
 ;;=4^M85.80
 ;;^UTILITY(U,$J,358.3,21906,2)
 ;;=^5014473
 ;;^UTILITY(U,$J,358.3,21907,0)
 ;;=N62.^^89^1038^24
 ;;^UTILITY(U,$J,358.3,21907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21907,1,3,0)
 ;;=3^Gynecomastia
 ;;^UTILITY(U,$J,358.3,21907,1,4,0)
 ;;=4^N62.
 ;;^UTILITY(U,$J,358.3,21907,2)
 ;;=^5015790
 ;;^UTILITY(U,$J,358.3,21908,0)
 ;;=E10.43^^89^1038^6
 ;;^UTILITY(U,$J,358.3,21908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21908,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,21908,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,21908,2)
 ;;=^5002607
 ;;^UTILITY(U,$J,358.3,21909,0)
 ;;=E10.59^^89^1038^4
 ;;^UTILITY(U,$J,358.3,21909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21909,1,3,0)
 ;;=3^DM Type 1 w/ Circulatory Complications
 ;;^UTILITY(U,$J,358.3,21909,1,4,0)
 ;;=4^E10.59
 ;;^UTILITY(U,$J,358.3,21909,2)
 ;;=^5002612
 ;;^UTILITY(U,$J,358.3,21910,0)
 ;;=E10.618^^89^1038^5
 ;;^UTILITY(U,$J,358.3,21910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21910,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Arthropathy
 ;;^UTILITY(U,$J,358.3,21910,1,4,0)
 ;;=4^E10.618
 ;;^UTILITY(U,$J,358.3,21910,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,21911,0)
 ;;=E10.621^^89^1038^7
 ;;^UTILITY(U,$J,358.3,21911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21911,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,21911,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,21911,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,21912,0)
 ;;=E10.622^^89^1038^11
 ;;^UTILITY(U,$J,358.3,21912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21912,1,3,0)
 ;;=3^DM Type 1 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,21912,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,21912,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,21913,0)
 ;;=E10.65^^89^1038^10
 ;;^UTILITY(U,$J,358.3,21913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21913,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycermia
